Total Revenues for Q2 Up 25%
Continue ReadingTag: diagnostics
Akers Biosciences Announces Conference Call to Discuss FY 2016 Earnings
THOROFARE, NJ -- (Marketwired) -- 04/10/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company"…
Continue ReadingAkers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants
THOROFARE, NJ -- (Marketwired) -- 01/09/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company"…
Continue ReadingNeurotrack Raises $2 Million Series A Led by Founders Fund
Pre-Eminent Team Backs New "Behavioral Biomarker" for Potential Earlier Detection of Alzheimer-s Disease; New Tool for…
Continue Reading